Latest Breaking News On - Ascletis pharma - Page 1 : comparemela.com

Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024

/PRNewswire/ Gannex Pharma Co., Ltd. ("Gannex"), a wholly-owned company of Ascletis Pharma Inc. (HKEX:1672, "Ascletis") dedicated to the research and.

United statesHong kongJinzij wuHong kong stock exchangeAscletis pharma incPrnewswire gannex pharma co ltdGannex pharma co ltdAscletis pharmaEuropean associationLiver enzymesLipids biomarkers

Ascletis Pharma (OTCMKTS:ASCLF) Trading Down 25 2%

Ascletis Pharma (OTCMKTS:ASCLF) Trading Down 25 2%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ascletis pharmaAscletis pharma incAscletis pharma company profileGet free reportPharma incMainland chinaAscletis pharma daily

Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances In Treatment Protocols And Drug Developments

Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances In Treatment Protocols And Drug Developments
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Eli lillyAscletis pharmaDenovo biopharmaCelldex therapeuticsBiopharma coMenarini groupBpgbio incBayer agXynomic pharmaceuticalsAadi bioscience incPhotonamic gmbh coPipeline development activitiesCollaborative effortsMarket analysisEmerging drugs

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

Beijing wants cheaper, better drugs. That’s pressuring drug makers to innovate as generics become more competitive.

Hong kongSan franciscoUnited statesBritish columbiaNew yorkStephen peepelsLin xiaoweiAscletis pharmaMichael yu dechaoMorgan huangCharles li xiaojiaHogan lovellsHuang guobinInnovent biologicsZai labJp morgan chase co

Short Interest in Ascletis Pharma Inc (OTCMKTS:ASCLF) Decreases By 92 4%

Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 53,800 shares, a decrease of 92.4% from the December 31st total of 706,000 shares. Based on an average daily trading volume, of 2,900 […]

Ascletis pharmaAscletis pharma incGet free reportPharma incMainland chinaAscletis pharma dailyOtcmkts asclf